BlackRock
LEGN icon

BlackRock’s Legend Biotech LEGN Stock Holding History

BlackRock’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$137M Buy
4,726,534
+41,991
+0.9% +$1.13M ﹤0.01% 2036
2026
Q1 		$84.7M Buy
4,684,543
+407,630
+10% +$7.77M ﹤0.01% 2206
2025
Q4 		$93M Sell
4,276,913
-217,710
-5% -$6.24M ﹤0.01% 2145
2025
Q3 		$147M Buy
4,494,623
+246,055
+6% +$9.08M ﹤0.01% 1853
2025
Q2 		$151M Sell
4,248,568
-278,432
-6% -$9.02M ﹤0.01% 1790
2025
Q1 		$154M Sell
4,527,000
-81,452
-2% -$2.92M ﹤0.01% 1739
2024
Q4 		$150M Buy
4,608,452
+113,373
+3% +$4.7M ﹤0.01% 1828
2024
Q3 		$219M Sell
4,495,079
-1,226,198
-21% -$65.3M ﹤0.01% 1606
2024
Q2 		$253M Buy
5,721,277
+337,247
+6% +$15.6M 0.01% 1455
2024
Q1 		$302M Buy
5,384,030
+117,842
+2% +$7.11M 0.01% 1364
2023
Q4 		$317M Buy
5,266,188
+645,154
+14% +$40.9M 0.01% 1337
2023
Q3 		$310M Sell
4,621,034
-122,560
-3% -$8.51M 0.01% 1249
2023
Q2 		$327M Buy
4,743,594
+615,641
+15% +$40.2M 0.01% 1228
2023
Q1 		$199M Buy
4,127,953
+250,146
+6% +$12.2M 0.01% 1537
2022
Q4 		$194M Buy
3,877,807
+146,025
+4% +$7.07M 0.01% 1553
2022
Q3 		$152M Buy
3,731,782
+583,851
+19% +$27.4M 0.01% 1678
2022
Q2 		$173M Buy
3,147,931
+101,702
+3% +$4.29M 0.01% 1636
2022
Q1 		$111M Buy
3,046,229
+639,828
+27% +$25.3M ﹤0.01% 2078
2021
Q4 		$112M Buy
2,406,401
+1,568,474
+187% +$79.6M ﹤0.01% 2146
2021
Q3 		$42.4M Buy
837,927
+35,330
+4% +$1.47M ﹤0.01% 2766
2021
Q2 		$32.9M Buy
802,597
+593,618
+284% +$20.2M ﹤0.01% 2983
2021
Q1 		$6.07M Buy
208,979
+16,507
+9% +$450K ﹤0.01% 3848
2020
Q4 		$5.42M Buy
+192,472
New +$5.54M ﹤0.01% 3674
2020
Q3 		– Sell
-8
Closed – – 5108
2020
Q2 		$0 Buy
+8
New +$313 ﹤0.01% 5075

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock's LEGN Position: Q2 2026 in Review

BlackRock increased its Legend Biotech (LEGN) stake by 0.9% in Q2 2026, buying an estimated $1.13M and bringing the position to 4,726,534 shares worth $137M. The position accounts for ﹤0.01% of the portfolio, ranked #2036.

BlackRock first reported a position in LEGN in Q2 2020 and has held it in 24 quarters since. The position peaked at $327M in Q2 2023. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • BlackRock held 4,726,534 shares of Legend Biotech worth $137M as of Q2 2026.
  • BlackRock bought 41,991 Legend Biotech shares in Q2 2026, an estimated $1.13M.
  • Legend Biotech made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2036 holding.
  • BlackRock first reported a position in Legend Biotech in Q2 2020 and has held it in 24 quarters since.
  • BlackRock's Legend Biotech position peaked at $327M in Q2 2023.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.